Professional & Aesthetics.
The business behind the treatment room, medical aesthetics, spas, and salons across Asia.
Humedix Hosts Second Brazil Medical Exchange for Dermal Fillers
The Korean aesthetic firm, a Huons Group subsidiary, brought Brazilian medical professionals to its Pangyo headquarters on October 28 to review scientific data and manufacturing processes for its Rennova HA fillers.
Korean Ardens Lifescience Wins $175,000 MedTech Innovator Grand Prize
The startup, developing a minimally invasive lung cancer treatment device, secured the top award at the 2026 MedTech Innovator Asia Pacific Grand Finals in Singapore.
Korean Noul to Supply AI Cervical Cancer System in Bosnia
Korean medical AI firm Noul will provide at least 16 miLab CER units over three years to Bosnia and Herzegovina, targeting private diagnostic labs.
Galderma, L'Oréal, Natura Develop Rapid Weight Loss Skin Care
Global beauty firms Galderma, L'Oréal, and Natura are addressing facial volume loss from rapid weight reduction. This market for clinical treatments could reach US$2 billion over the next five years.
S. Korea Ministry Inspects Clinics Over Obesity Drug Rules
Seoul's Ministry of Health and Welfare will conduct nationwide site visits, targeting institutions suspected of bypassing prescription and dispensing rules for self-injectable obesity treatments.
Daewoong Pharmaceutical Reports 20% Nabota Sales Growth in South America
Daewoong Pharmaceutical's Nabota botulinum toxin product sees 20% annual sales growth in South America, supported by a Master Class in Buenos Aires.
Merz Aesthetics Launches SkinGivity Solutions, Citing Korea
The medical aesthetics company introduces its SkinGivity Solutions concept, integrating injectables and devices for long-term skin health management.
Hugel Trains Global Professionals in K-Aesthetics Techniques
The Korean medical aesthetics firm gathered 20 specialists from five continents for its Aesthetic Excellence Summit last week, focusing on botulinum toxin and dermal filler applications.
Hugel Brings 20 Global Doctors to Korea for Aesthetics Training
South Korean medical aesthetics firm Hugel hosted its three-day Aesthetic Excellence Summit 2026, training 20 medical professionals from four continents in botulinum toxin and dermal filler techniques.
VAIM, Bloomage Biotech Launch JuveLook in China
The medical aesthetics product, approved by China's NMPA in July, was introduced at a Beijing event attended by 500 professionals.
Classys Names Bae Jung-hee CCO, Targets $1 Billion Revenue by 2030
The Korean medical aesthetics device maker aims to restructure global sales and marketing under the former Bain & Company partner, who will focus on international market expansion.
Korea Targets Aesthetic Medical Device Exports, Eyes Asian Markets
The Korea Health Industry Development Institute projects medical device exports to reach $6.2 billion in 2026, with a strategic focus on aesthetic devices and digital health solutions for key Asian economies.
GC WellBeing, 365mc Partner on RZL-012 Fat Reduction in Korea
The collaboration aims to establish clinical evidence and treatment protocols for the injectable drug candidate, designed to reduce localized fat, supporting GC WellBeing's medical aesthetics expansion.
Humedix Gathers 500 for Re2O Human Tissue Product Safety Summit
South Korean firm Humedix convened 500 healthcare professionals in Seoul on October 9, 2026, to discuss its human tissue-derived product, Re2O, used in aesthetic and reconstructive procedures.
Korea's Cosmetic Tourism Surges, VAT Refunds End 2025
Dermatology and plastic surgery accounted for 74.1% of foreign patient visits to South Korea in 2025, reaching 1.55 million, as the cosmetic VAT refund scheme expired.
CGBio Trains 110 Doctors in Bali on Regenerative Aesthetics
South Korean firm CGBio will host its "Meet the Masters" event on October 16-17, 2026, bringing together medical professionals from 15 countries for training focused on DCLASSY CaHA and combination treatments.
Humedix Commits ₩3.3 Billion to South Korean Aesthetics R&D
South Korean aesthetics firm Humedix will invest in research and development through 2029, backed by a government program to expand medical product exports.
CGBio promotes FACETEM in Colombia, targets Latin America expansion
The Korean medical aesthetics firm held "Meet the Masters LATAM 2026" in Bogotá from September 3-4, showcasing its calcium hydroxyapatite filler.
Hugel Trains 25 Taiwanese Professionals on Letybo, The Chaeum in Korea
Hugel hosted 25 Taiwanese healthcare professionals for its LEAD program last week, aiming to boost market share for Letybo botulinum toxin and The Chaeum HA filler in Taiwan.
Alteogen Biologics Licenses Papilocare HPV Device for Korea
The Korean biotech firm secured rights from Spain's Procare Health today for an intravaginal gel device to manage human papillomavirus (HPV) infection and cervical lesions.
365mc Bangkok Clinic Promotes Body Contouring on SURGERY WARS
Korean obesity treatment provider 365mc recently featured its Bangkok clinic on the Thai makeover reality show “SURGERY WARS.” The company reported this appearance aimed to increase its visibility within Thailand's medical aesthetics market, showcasing specialized body-contouring procedures including localized fat removal and fat transfer techniques.
AriBio Lab Secures Indonesian BPOM Approval for Bidan HA Fillers
Korean biotechnology firm AriBio Lab has gained Indonesian drug regulator approval for four Bidan hyaluronic acid (HA) filler products. This enables the company's entry into Indonesia's medical aesthetics market, a strategic expansion for the group.
Korean Radiology Clinics Risk Closure Over Imaging Reimbursement Cuts
South Korean radiologists warn that planned reductions in diagnostic imaging reimbursement rates, alongside relaxed staffing requirements for MRI equipment, could force some clinics to close. The Korean Association of Radiologists (KAR) projects significant financial strain and potential quality control issues.
GC Genome Reports Strong H1 2026 Results, Operating Profit Jumps 119%
South Korean diagnostics firm GC Genome announced a 119 percent increase in operating profit for the first half of 2026, driven by growth in its core diagnostic tests and improved financial performance.
Hugel Reports Record First-Half Earnings on Botulinum Toxin and Americas Growth
Korean medical aesthetics firm Hugel announced its strongest first-half performance, driven by increased global demand for its botulinum toxin products and expansion in the Americas. The company reported significant gains in sales, operating profit, and net profit for the six-month period.
Korea University Expert Professor Kim Sin-gon Discusses AI's Impact on Medical Practice, Implications for Asia's Medical Aesthetics
Professor Kim Sin-gon of Korea University College of Medicine analyzes how artificial intelligence will reshape medical roles, not specialties. His insights reveal that traditional medical strengths are now AI's domain, urging a focus on human-centric skills. This analysis carries significant implications for Asia's expanding medical aesthetics sector, where technology integration and patient interaction are both critical.